1	Role	role	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	Egr-2	egr-2	_	_	_	_	_	_	_
4	in	in	_	_	_	_	_	_	_
5	up-regulation	up-regulation	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	Fas	Fas	_	_	_	_	_	_	_
8	ligand	ligand	_	_	_	_	_	_	_
9	in	in	_	_	_	_	_	_	_
10	normal	normal	_	_	_	_	_	_	_
11	T	t	_	_	_	_	_	_	_
12	cells	cell	_	_	_	_	_	_	_
13	and	and	_	_	_	_	_	_	_
14	aberrant	aberrant	_	_	_	_	_	_	_
15	double-negative	double-negative	_	_	_	_	_	_	_
16	lpr	lpr	_	_	_	_	_	_	_
17	and	and	_	_	_	_	_	_	_
18	gld	gld	_	_	_	_	_	_	_
19	T	t	_	_	_	_	_	_	_
20	cells	cell	_	_	_	_	_	_	_
21	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	previously	previously	_	_	_	_	_	_	_
3	identified	identify	_	_	_	_	_	_	_
4	a	a	_	_	_	_	_	_	_
5	Fas	Fas	_	_	_	_	_	_	_
6	ligand	ligand	_	_	_	_	_	_	_
7	regulatory	regulatory	_	_	_	_	_	_	_
8	element	element	_	_	_	_	_	_	_
9	(	(	_	_	_	_	_	_	_
10	FLRE	FLRE	_	_	_	_	_	_	_
11	)	)	_	_	_	_	_	_	_
12	in	in	_	_	_	_	_	_	_
13	the	the	_	_	_	_	_	_	_
14	Fas	Fas	_	_	_	_	_	_	_
15	ligand	ligand	_	_	_	_	_	_	_
16	(	(	_	_	_	_	_	_	_
17	fasL	fasl	_	_	_	_	_	_	_
18	)	)	_	_	_	_	_	_	_
19	promoter	promoter	_	_	_	_	_	_	_
20	that	that	_	_	_	_	_	_	_
21	binds	bind	_	_	_	_	_	_	_
22	Egr	Egr	_	_	_	_	_	_	_
23	family	family	_	_	_	_	_	_	_
24	proteins	protein	_	_	_	_	_	_	_
25	and	and	_	_	_	_	_	_	_
26	demonstrated	demonstrate	_	_	_	_	_	_	_
27	that	that	_	_	_	_	_	_	_
28	Egr-3	Egr-3	_	_	_	_	_	_	_
29	(	(	_	_	_	_	_	_	_
30	PILOT	PILOT	_	_	_	_	_	_	_
31	)	)	_	_	_	_	_	_	_
32	but	but	_	_	_	_	_	_	_
33	not	not	_	_	_	_	_	_	_
34	Egr-1	egr-1	_	_	_	_	_	_	_
35	(	(	_	_	_	_	_	_	_
36	NGFI-A	NGFI-A	_	_	_	_	_	_	_
37	,	,	_	_	_	_	_	_	_
38	Krox-24	Krox-24	_	_	_	_	_	_	_
39	,	,	_	_	_	_	_	_	_
40	Tis-8	tis-8	_	_	_	_	_	_	_
41	,	,	_	_	_	_	_	_	_
42	and	and	_	_	_	_	_	_	_
43	Zif-268	zif-268	_	_	_	_	_	_	_
44	)	)	_	_	_	_	_	_	_
45	induces	induce	_	_	_	_	_	_	_
46	transcription	transcription	_	_	_	_	_	_	_
47	of	of	_	_	_	_	_	_	_
48	fasL	fasl	_	_	_	_	_	_	_
49	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	aberrant	aberrant	_	_	_	_	_	_	_
3	CD4(-)CD8(-)	cd4(-)cd8(-)	_	_	_	_	_	_	_
4	T	t	_	_	_	_	_	_	_
5	cells	cell	_	_	_	_	_	_	_
6	from	from	_	_	_	_	_	_	_
7	lpr/lpr	lpr/lpr	_	_	_	_	_	_	_
8	and	and	_	_	_	_	_	_	_
9	gld/gld	gld/gld	_	_	_	_	_	_	_
10	mice	mouse	_	_	_	_	_	_	_
11	,	,	_	_	_	_	_	_	_
12	which	which	_	_	_	_	_	_	_
13	have	have	_	_	_	_	_	_	_
14	mutations	mutation	_	_	_	_	_	_	_
15	in	in	_	_	_	_	_	_	_
16	the	the	_	_	_	_	_	_	_
17	genes	gene	_	_	_	_	_	_	_
18	encoding	encode	_	_	_	_	_	_	_
19	Fas	Fas	_	_	_	_	_	_	_
20	and	and	_	_	_	_	_	_	_
21	FasL	FasL	_	_	_	_	_	_	_
22	,	,	_	_	_	_	_	_	_
23	respectively	respectively	_	_	_	_	_	_	_
24	,	,	_	_	_	_	_	_	_
25	have	have	_	_	_	_	_	_	_
26	an	an	_	_	_	_	_	_	_
27	activated	activate	_	_	_	_	_	_	_
28	phenotype	phenotype	_	_	_	_	_	_	_
29	and	and	_	_	_	_	_	_	_
30	constitutively	constitutively	_	_	_	_	_	_	_
31	express	express	_	_	_	_	_	_	_
32	high	high	_	_	_	_	_	_	_
33	levels	level	_	_	_	_	_	_	_
34	of	of	_	_	_	_	_	_	_
35	fasL	fasl	_	_	_	_	_	_	_
36	mRNA	mrna	_	_	_	_	_	_	_
37	,	,	_	_	_	_	_	_	_
38	prompting	prompt	_	_	_	_	_	_	_
39	us	us	_	_	_	_	_	_	_
40	to	to	_	_	_	_	_	_	_
41	ask	ask	_	_	_	_	_	_	_
42	what	what	_	_	_	_	_	_	_
43	role	role	_	_	_	_	_	_	_
44	if	if	_	_	_	_	_	_	_
45	any	any	_	_	_	_	_	_	_
46	the	the	_	_	_	_	_	_	_
47	FLRE	FLRE	_	_	_	_	_	_	_
48	and	and	_	_	_	_	_	_	_
49	Egr	Egr	_	_	_	_	_	_	_
50	family	family	_	_	_	_	_	_	_
51	proteins	protein	_	_	_	_	_	_	_
52	have	have	_	_	_	_	_	_	_
53	in	in	_	_	_	_	_	_	_
54	this	this	_	_	_	_	_	_	_
55	aberrant	aberrant	_	_	_	_	_	_	_
56	expression	expression	_	_	_	_	_	_	_
57	of	of	_	_	_	_	_	_	_
58	fasL	fasl	_	_	_	_	_	_	_
59	.	.	_	_	_	_	_	_	_

1	Unstimulated	unstimulated	_	_	_	_	_	_	_
2	MRL-lpr/lpr	MRL-lpr/lpr	_	_	_	_	_	_	_
3	and	and	_	_	_	_	_	_	_
4	C3H-gld/gld	c3h-gld/gld	_	_	_	_	_	_	_
5	CD4(-)CD8(-)	cd4(-)cd8(-)	_	_	_	_	_	_	_
6	T	t	_	_	_	_	_	_	_
7	cells	cell	_	_	_	_	_	_	_
8	constitutively	constitutively	_	_	_	_	_	_	_
9	contained	contain	_	_	_	_	_	_	_
10	high	high	_	_	_	_	_	_	_
11	levels	level	_	_	_	_	_	_	_
12	of	of	_	_	_	_	_	_	_
13	two	two	_	_	_	_	_	_	_
14	proteins	protein	_	_	_	_	_	_	_
15	that	that	_	_	_	_	_	_	_
16	bound	bind	_	_	_	_	_	_	_
17	to	to	_	_	_	_	_	_	_
18	the	the	_	_	_	_	_	_	_
19	FLRE	flre	_	_	_	_	_	_	_
20	.	.	_	_	_	_	_	_	_

1	Supershift	Supershift	_	_	_	_	_	_	_
2	analysis	analysis	_	_	_	_	_	_	_
3	revealed	reveal	_	_	_	_	_	_	_
4	these	these	_	_	_	_	_	_	_
5	proteins	protein	_	_	_	_	_	_	_
6	to	to	_	_	_	_	_	_	_
7	be	be	_	_	_	_	_	_	_
8	Egr-1	egr-1	_	_	_	_	_	_	_
9	and	and	_	_	_	_	_	_	_
10	Egr-2	egr-2	_	_	_	_	_	_	_
11	(	(	_	_	_	_	_	_	_
12	Krox-20	Krox-20	_	_	_	_	_	_	_
13	)	)	_	_	_	_	_	_	_
14	;	;	_	_	_	_	_	_	_
15	Egr-3	Egr-3	_	_	_	_	_	_	_
16	was	be	_	_	_	_	_	_	_
17	not	not	_	_	_	_	_	_	_
18	detected	detect	_	_	_	_	_	_	_
19	.	.	_	_	_	_	_	_	_

1	Activation	Activation	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	normal	normal	_	_	_	_	_	_	_
4	lymph	lymph	_	_	_	_	_	_	_
5	node	node	_	_	_	_	_	_	_
6	cells	cell	_	_	_	_	_	_	_
7	resulted	result	_	_	_	_	_	_	_
8	in	in	_	_	_	_	_	_	_
9	increased	increase	_	_	_	_	_	_	_
10	expression	expression	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	Egr-1	Egr-1	_	_	_	_	_	_	_
13	,	,	_	_	_	_	_	_	_
14	-2	-2	_	_	_	_	_	_	_
15	,	,	_	_	_	_	_	_	_
16	and	and	_	_	_	_	_	_	_
17	-3	-3	_	_	_	_	_	_	_
18	.	.	_	_	_	_	_	_	_

1	As	as	_	_	_	_	_	_	_
2	with	with	_	_	_	_	_	_	_
3	egr-3	egr-3	_	_	_	_	_	_	_
4	,	,	_	_	_	_	_	_	_
5	expression	expression	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	egr-2	egr-2	_	_	_	_	_	_	_
8	was	be	_	_	_	_	_	_	_
9	blocked	block	_	_	_	_	_	_	_
10	by	by	_	_	_	_	_	_	_
11	cyclosporin	cyclosporin	_	_	_	_	_	_	_
12	A	a	_	_	_	_	_	_	_
13	.	.	_	_	_	_	_	_	_

1	Although	although	_	_	_	_	_	_	_
2	overexpressed	overexpresse	_	_	_	_	_	_	_
3	Egr-1	egr-1	_	_	_	_	_	_	_
4	was	be	_	_	_	_	_	_	_
5	ineffective	ineffective	_	_	_	_	_	_	_
6	,	,	_	_	_	_	_	_	_
7	overexpressed	overexpresse	_	_	_	_	_	_	_
8	Egr-2	egr-2	_	_	_	_	_	_	_
9	was	be	_	_	_	_	_	_	_
10	as	as	_	_	_	_	_	_	_
11	potent	potent	_	_	_	_	_	_	_
12	as	as	_	_	_	_	_	_	_
13	Egr-3	egr-3	_	_	_	_	_	_	_
14	in	in	_	_	_	_	_	_	_
15	inducing	induce	_	_	_	_	_	_	_
16	fasL	fasl	_	_	_	_	_	_	_
17	promoter-dependent	promoter-dependent	_	_	_	_	_	_	_
18	reporter	reporter	_	_	_	_	_	_	_
19	constructs	construct	_	_	_	_	_	_	_
20	in	in	_	_	_	_	_	_	_
21	T	t	_	_	_	_	_	_	_
22	cell	cell	_	_	_	_	_	_	_
23	hybridomas	hybridoma	_	_	_	_	_	_	_
24	and	and	_	_	_	_	_	_	_
25	HeLa	HeLa	_	_	_	_	_	_	_
26	cells	cell	_	_	_	_	_	_	_
27	,	,	_	_	_	_	_	_	_
28	and	and	_	_	_	_	_	_	_
29	both	both	_	_	_	_	_	_	_
30	up-regulated	up-regulate	_	_	_	_	_	_	_
31	endogenous	endogenous	_	_	_	_	_	_	_
32	fasL	fasl	_	_	_	_	_	_	_
33	mRNA	mrna	_	_	_	_	_	_	_
34	in	in	_	_	_	_	_	_	_
35	HeLa	HeLa	_	_	_	_	_	_	_
36	cells	cell	_	_	_	_	_	_	_
37	.	.	_	_	_	_	_	_	_

1	FasL-dependent	fasl-dependent	_	_	_	_	_	_	_
2	reporter	reporter	_	_	_	_	_	_	_
3	constructs	construct	_	_	_	_	_	_	_
4	in	in	_	_	_	_	_	_	_
5	MRL-lpr/lpr	MRL-lpr/lpr	_	_	_	_	_	_	_
6	and	and	_	_	_	_	_	_	_
7	C3H-gld/gld	c3h-gld/gld	_	_	_	_	_	_	_
8	CD4(-)CD8(-)	cd4(-)cd8(-)	_	_	_	_	_	_	_
9	T	t	_	_	_	_	_	_	_
10	cells	cell	_	_	_	_	_	_	_
11	were	be	_	_	_	_	_	_	_
12	constitutively	constitutively	_	_	_	_	_	_	_
13	active	active	_	_	_	_	_	_	_
14	,	,	_	_	_	_	_	_	_
15	and	and	_	_	_	_	_	_	_
16	this	this	_	_	_	_	_	_	_
17	activity	activity	_	_	_	_	_	_	_
18	was	be	_	_	_	_	_	_	_
19	largely	largely	_	_	_	_	_	_	_
20	prevented	prevent	_	_	_	_	_	_	_
21	by	by	_	_	_	_	_	_	_
22	mutation	mutation	_	_	_	_	_	_	_
23	of	of	_	_	_	_	_	_	_
24	the	the	_	_	_	_	_	_	_
25	critical	critical	_	_	_	_	_	_	_
26	Egr	Egr	_	_	_	_	_	_	_
27	family	family	_	_	_	_	_	_	_
28	binding	binding	_	_	_	_	_	_	_
29	element	element	_	_	_	_	_	_	_
30	.	.	_	_	_	_	_	_	_

1	Thus	thus	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	Egr-2	Egr-2	_	_	_	_	_	_	_
4	,	,	_	_	_	_	_	_	_
5	in	in	_	_	_	_	_	_	_
6	addition	addition	_	_	_	_	_	_	_
7	to	to	_	_	_	_	_	_	_
8	Egr-3	Egr-3	_	_	_	_	_	_	_
9	,	,	_	_	_	_	_	_	_
10	regulates	regulate	_	_	_	_	_	_	_
11	FasL	FasL	_	_	_	_	_	_	_
12	expression	expression	_	_	_	_	_	_	_
13	in	in	_	_	_	_	_	_	_
14	activated	activate	_	_	_	_	_	_	_
15	normal	normal	_	_	_	_	_	_	_
16	T	t	_	_	_	_	_	_	_
17	cells	cell	_	_	_	_	_	_	_
18	,	,	_	_	_	_	_	_	_
19	and	and	_	_	_	_	_	_	_
20	Egr-2	egr-2	_	_	_	_	_	_	_
21	is	be	_	_	_	_	_	_	_
22	likely	likely	_	_	_	_	_	_	_
23	to	to	_	_	_	_	_	_	_
24	play	play	_	_	_	_	_	_	_
25	a	a	_	_	_	_	_	_	_
26	direct	direct	_	_	_	_	_	_	_
27	role	role	_	_	_	_	_	_	_
28	in	in	_	_	_	_	_	_	_
29	aberrant	aberrant	_	_	_	_	_	_	_
30	fasL	fasl	_	_	_	_	_	_	_
31	up-regulation	up-regulation	_	_	_	_	_	_	_
32	in	in	_	_	_	_	_	_	_
33	lpr/lpr	lpr/lpr	_	_	_	_	_	_	_
34	and	and	_	_	_	_	_	_	_
35	gld/gld	gld/gld	_	_	_	_	_	_	_
36	CD4(-)CD8(-)	cd4(-)cd8(-)	_	_	_	_	_	_	_
37	T	t	_	_	_	_	_	_	_
38	cells	cell	_	_	_	_	_	_	_
39	.	.	_	_	_	_	_	_	_

